Fig. 1From: Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapyKaplan-Meier distant relapse-free survival analysis in the MDACC-based (GSE25066 [19]) dataset based on the pathological treatment response. (a) Survival outcomes of the intrinsic subtypes in patients that achieved a pathological complete response (pCR); (b) Survival outcomes of the risk of relapse score based on subtype and proliferation (ROR-P) groups in patients that achieved a pCR; (c) Survival outcomes of the intrinsic subtypes in patients that did not achieve a pCR; (d) Survival outcomes of the ROR-P groups in patients that did not achieve a pCRBack to article page